There are 2789 resources available
1663P - Prognostic impact of baseline neutrophil-to-lymphocyte ratio (NLR) and its change during treatment for overall survival in advanced SCLC
Presenter: MASASHI ISHIHARA
Session: ePoster Display
1665TiP - High-dose vs standard-dose thoracic radiotherapy for extensive stage small cell lung cancer: Study protocol for a phase III randomized trial
Presenter: Yufan Yang
Session: ePoster Display
1666TiP - Phase II study of berzosertib (M6620) + topotecan in patients with relapsed platinum-resistant SCLC: DDRiver SCLC 250
Presenter: Anish Thomas
Session: ePoster Display
1667TiP - Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study
Presenter: Luis Paz-Ares
Session: ePoster Display
1596P - SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis
Presenter: Anna Pous
Session: ePoster Display
1597P - Vaccination against SARS-CoV-2 infection in patients with solid tumors: Experience from Institute for Oncology and Radiology of Serbia (IORS)
Presenter: Ognjen Djurmez
Session: ePoster Display
1598P - Acceptance of SARS-CoV-2 vaccination among patients with cancer undergoing immunosuppressive therapy: Portuguese study
Presenter: Maria João de Sousa
Session: ePoster Display
1599P - Vaccination in the COVID-19 era: Attitudes amongst oncology patients
Presenter: Sinead Horan
Session: ePoster Display
1600P - Suboptimal response to COVID-19 mRNA vaccines in older patients with cancer
Presenter: Thierry Landre
Session: ePoster Display